Ifeanichukwu O Okike1, Sonia Ribeiro2, Mary E Ramsay2, Paul T Heath3, Mike Sharland3, Shamez N Ladhani4. 1. Paediatric Infectious Diseases Research Group and Vaccine Institute, St George's, University of London, London, UK; Immunisation Department, Public Health England, London, UK. 2. Immunisation Department, Public Health England, London, UK. 3. Paediatric Infectious Diseases Research Group and Vaccine Institute, St George's, University of London, London, UK. 4. Paediatric Infectious Diseases Research Group and Vaccine Institute, St George's, University of London, London, UK; Immunisation Department, Public Health England, London, UK. Electronic address: shamez.ladhani@phe.gov.uk.
Abstract
BACKGROUND: Meningitis remains one of the most feared infectious diseases worldwide, yet there are few population-based studies on the epidemiology, causes, or trends over time in meningitis, especially in industrialised countries. Our aim was to do such a study using routinely reported data available in England and Wales. METHODS: In England and Wales, UK National Health Service hospitals routinely report laboratory-confirmed pathogens electronically to Public Health England. Records of all positive bacterial, mycobacterial, and fungal results from cerebrospinal fluid or from blood cultures in patients with clinical meningitis were extracted for analysis. The percentage change in annual incidence was estimated using linear regression analysis of the log of the annual incidence. FINDINGS: During 2004-11, 7061 cases of meningitis were reported (mean annual incidence 1·62 per 100,000 people, 95% CI 1·58-1·66), including 2594 cases in children (37%). The incidence of bacterial (1·44 per 100,000 people, 1·41-1·48), fungal (0·09, 0·08-0·10), and mycobacterial (0·09, 0·08-0·09) meningitis remained stable overall and across the age groups, apart from significant year-on-year increases in children younger than 3 months (978 cases; incidence 72·2 per 100,000 people; annual increase 7·4%, 5·1-9·8; p<0·0001) driven mainly by group B streptococci (GBS), and in adults aged 65 years or older (752 cases; incidence 1·2 per 100,000 people; annual increase 3·0%, 1·4-4·8; p<0·0001) primarily because of Escherichia coli. By contrast, meningococcal meningitis rates declined steadily, but remained the most common cause of meningitis in children. Overall, five groups of bacteria accounted for 60% (3790/6286) of bacterial meningitis cases: Neisseria meningitidis (1350 cases, 22%), Streptococcus pneumoniae (1143, 18%), Staphylococcus aureus (652, 10%), GBS (326, 5%), and E coli (319, 5%). INTERPRETATION: In England and Wales, laboratory-based surveillance shows a remarkably stable incidence of bacterial, fungal, and mycobacterial meningitis in recent years, although there were differences in individual trends among the main pathogens causing meningitis in different age groups. FUNDING: None.
BACKGROUND:Meningitis remains one of the most feared infectious diseases worldwide, yet there are few population-based studies on the epidemiology, causes, or trends over time in meningitis, especially in industrialised countries. Our aim was to do such a study using routinely reported data available in England and Wales. METHODS: In England and Wales, UK National Health Service hospitals routinely report laboratory-confirmed pathogens electronically to Public Health England. Records of all positive bacterial, mycobacterial, and fungal results from cerebrospinal fluid or from blood cultures in patients with clinical meningitis were extracted for analysis. The percentage change in annual incidence was estimated using linear regression analysis of the log of the annual incidence. FINDINGS: During 2004-11, 7061 cases of meningitis were reported (mean annual incidence 1·62 per 100,000 people, 95% CI 1·58-1·66), including 2594 cases in children (37%). The incidence of bacterial (1·44 per 100,000 people, 1·41-1·48), fungal (0·09, 0·08-0·10), and mycobacterial (0·09, 0·08-0·09) meningitis remained stable overall and across the age groups, apart from significant year-on-year increases in children younger than 3 months (978 cases; incidence 72·2 per 100,000 people; annual increase 7·4%, 5·1-9·8; p<0·0001) driven mainly by group B streptococci (GBS), and in adults aged 65 years or older (752 cases; incidence 1·2 per 100,000 people; annual increase 3·0%, 1·4-4·8; p<0·0001) primarily because of Escherichia coli. By contrast, meningococcal meningitis rates declined steadily, but remained the most common cause of meningitis in children. Overall, five groups of bacteria accounted for 60% (3790/6286) of bacterial meningitis cases: Neisseria meningitidis (1350 cases, 22%), Streptococcus pneumoniae (1143, 18%), Staphylococcus aureus (652, 10%), GBS (326, 5%), and E coli (319, 5%). INTERPRETATION: In England and Wales, laboratory-based surveillance shows a remarkably stable incidence of bacterial, fungal, and mycobacterial meningitis in recent years, although there were differences in individual trends among the main pathogens causing meningitis in different age groups. FUNDING: None.
Authors: Samantha J Dando; Alan Mackay-Sim; Robert Norton; Bart J Currie; James A St John; Jenny A K Ekberg; Michael Batzloff; Glen C Ulett; Ifor R Beacham Journal: Clin Microbiol Rev Date: 2014-10 Impact factor: 26.132
Authors: C David Owen; Petra Lukacik; Jane A Potter; Olivia Sleator; Garry L Taylor; Martin A Walsh Journal: J Biol Chem Date: 2015-09-14 Impact factor: 5.157
Authors: Fiona McQuaid; Christine Jones; Zoe Stevens; Jane Plumb; Rhona Hughes; Helen Bedford; Merryn Voysey; Paul T Heath; Matthew D Snape Journal: BMJ Open Date: 2016-04-20 Impact factor: 2.692
Authors: Martin C Gulliford; Michael V Moore; Paul Little; Alastair D Hay; Robin Fox; A Toby Prevost; Dorota Juszczyk; Judith Charlton; Mark Ashworth Journal: BMJ Date: 2016-07-04
Authors: Emma C Wall; Mavuto Mukaka; Brigitte Denis; Veronica S Mlozowa; Malango Msukwa; Khumbo Kasambala; Mulinda Nyrienda; Theresa J Allain; Brian Faragher; Robert S Heyderman; David G Lalloo Journal: PLoS One Date: 2017-10-27 Impact factor: 3.240